文献速递瓣膜外科

老年患者二尖瓣修复与置换的结局比较

Outcomes of Mitral Valve Repair Versus Replacement in the Elderly.
PubMed 文献 · Ann Thorac Surg · 2019-09-09

本研究评估75岁及以上老年患者二尖瓣手术的结局,单中心2010至2018年472例患者中64%接受修复、36%接受置换。修复与置换的1年及5年生存率相似,但置换组再入院率更高;修复组5年免于至少中度二尖瓣反流率为86%。

要点

  • 老年患者二尖瓣修复与置换的1年及5年生存率无显著差异。
  • 二尖瓣置换组1年及5年免于再入院率均低于修复组。
  • 修复组5年免于至少中度二尖瓣反流率为86%,结果持久。

核心结论

  • 老年患者二尖瓣手术结局可接受,5年生存率约64%。
  • 老年患者二尖瓣修复可能不带来生存优势,但可持久实施。

研究设计与样本

  • 单中心回顾性研究,纳入2010至2018年75岁及以上接受二尖瓣手术的患者472例。
  • 按二尖瓣修复(301例,64%)或置换(171例,36%)分层,主要结局为死亡。
  • 采用多因素Cox回归进行风险调整,并针对退行性病变孤立非再次手术进行亚组分析。

主要发现

  • 术后并发症在两组间相当。
  • 退行性病变孤立二尖瓣手术亚组中,修复与置换的早期或晚期死亡率无差异,但修复组再入院率更低。
  • 修复组5年免于至少中度二尖瓣反流率为86%,两组免于二尖瓣再次手术率相当。

临床怎么用

  • 老年患者选择二尖瓣修复或置换时,应权衡再入院风险与修复的持久性。
  • 二尖瓣修复在老年患者中可持久实施,但不应期望其带来生存优势。

局限性

  • 单中心回顾性研究,可能存在选择偏倚和未测量混杂。
  • 亚组分析样本量有限,结果需谨慎解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluated outcomes of mitral valve surgery (MVS) in the elderly. METHODS: Patients 75 years or older undergoing MVS at a single center between 2010 and 2018 were included. Patients were stratified into mitral valve repair (MVr) or replacement (MVR). The primary outcome was mortality. Secondary outcomes included postoperative complications, readmissions, and freedom from at least moderate mitral regurgitation. Multivariable Cox regression was used for risk adjustment. A subanalysis of isolated, non-reoperative MVS for degenerative disease was also performed. RESULTS: Elderly patients (n = 472) underwent MVS, 301 (64%) with MVr and 171 (36%) with MVR. The majority of cases (68%) were performed for degenerative etiologic process. Survival was similar between MVr and MVR at 1 year (84% versus 86%; P = .40) and 5 years (64% versus 64%; P = .59). Postoperative complications were also comparable. Freedom from readmission was lower in the MVR cohort at 1 year (57% versus 68%; P = .02) and 5 years (33% versus 43%; P = .02). In isolated MVS for degenerative etiologic process, there was no difference in early or late mortality between MVr and MVR, although readmissions were lower with MVr. Overall, freedom from mitral valve reoperation was comparable, and the freedom from at least moderate regurgitation was 86% at 5 years in the MVr group. CONCLUSIONS: This study indicates that the outcomes of elderly patients undergoing MVS are acceptable with approximately 64% survival at 5 years. Our data suggest that MVr in the elderly may not confer a survival advantage but can be performed with durable results.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Seese LM, Sultan I, Gleason TG, et al. Outcomes of Mitral Valve Repair Versus Replacement in the Elderly. Ann Thorac Surg. 2019. PMID: 31513777. doi:10.1016/j.athoracsur.2019.07.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。